2011
DOI: 10.1016/j.ejmg.2010.09.001
|View full text |Cite
|
Sign up to set email alerts
|

De novo microduplication at 22q11.21 in a patient with VACTERL association

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
46
0

Year Published

2012
2012
2018
2018

Publication Types

Select...
8

Relationship

6
2

Authors

Journals

citations
Cited by 56 publications
(49 citation statements)
references
References 25 publications
3
46
0
Order By: Relevance
“…The patient affected with all of the 6 core VACTERL features and her mother had a 22q11.2 micro duplication overlapping 1.4 Mb of the de novo duplication in a VACTERL patient described by Schramm et al [2011]. This patient had vertebral fusion, anal atresia, right-sided duplicated kidney, and additional non-VACTERL deformations.…”
Section: Cnvs Identified In the Rotterdam Vacterl Cohortmentioning
confidence: 99%
“…The patient affected with all of the 6 core VACTERL features and her mother had a 22q11.2 micro duplication overlapping 1.4 Mb of the de novo duplication in a VACTERL patient described by Schramm et al [2011]. This patient had vertebral fusion, anal atresia, right-sided duplicated kidney, and additional non-VACTERL deformations.…”
Section: Cnvs Identified In the Rotterdam Vacterl Cohortmentioning
confidence: 99%
“…Forty-one patients presented with three or more CFs of the VATER/VACTERL association, while six patients presented with only two, with or without further anomalies (VATER/VACTERL-like phenotype). 1 For the mutation-sequencing analysis, an additional 59 patients with VATER/VACTERL association and 60 patients with VATER/-VACTERL-like phenotype recruited within Germany were added to the patient sample, of which 18 patients were previously described in Schramm et al 15,16 An additional 26 patients with VATER/ VACTERL association were recruited within the AGORA project and were added to the sample for the mutation-sequencing analysis. The AGORA project is run within the Netherlands and patients are being recruited by pediatric surgeons and clinical geneticists of the Radboud University, Nijmegen Medical Centre, Nijmegen, the Netherlands.…”
Section: Subjects and Dna Isolationmentioning
confidence: 99%
“…None of the patients used for array-based analysis has been reported in our previous studies. 15,16 To optimize for detection of de novo CNVs, we only included patients with a negative family history of the disease. Forty-one patients presented with three or more CFs of the VATER/VACTERL association, while six patients presented with only two, with or without further anomalies (VATER/VACTERL-like phenotype).…”
Section: Subjects and Dna Isolationmentioning
confidence: 99%
See 1 more Smart Citation
“…There is substantial evidence that genetic factors contribute to the development of these malformations; in particular, CNV studies in sporadic patients have identified de novo events that occur in specific chromosomal regions (Bartels et al, 2011;Boocock & Donnai, 1987;Boyadjiev et al, 2004;Cuschieri & EUROCAT Working Group, 2001;Draaken et al, 2010;Falcone et al, 2007;Keppler-Noreuil, 2001;Ludwig et al, 2009;Marcelis et al, 2011;Schramm et al, 2011aSchramm et al, , 2011bShapiro et al, 1984). We hypothesized that CNVs affecting coding regions that occur after twinning might contribute to discordance in MZ twin pairs with ARM or the BEEC.…”
mentioning
confidence: 99%